已收录 268921 条政策
 政策提纲
  • 暂无提纲
Protocol for Evaluating In Vivo the Activation of the P2RX7 Immunomodulator
[摘要] BackgroundP2RX7 is a purinergic receptor with pleiotropic activities that is activated by high levels of extracellular ATP that are found in inflamed tissues. P2RX7 has immunomodulatory and anti-tumor proprieties and is therefore a therapeutic target for various diseases. Several compounds are developed to either inhibit or enhance its activation. However, studying their effect on P2RX7’s activities is limited to in vitro and ex vivo studies that require the use of unphysiological media that could affect its activation. Up to now, the only way to assess the activity of P2RX7 modulators on the receptor in vivo was in an indirect manner.ResultsWe successfully developed a protocol allowing the detection of P2RX7 activation in vivo in lungs of mice, by taking advantage of its unique macropore formation ability. The protocol is based on intranasal delivery of TO-PRO™-3, a non-permeant DNA intercalating dye, and fluorescence measurement by flow cytometry. We show that ATP enhances TO-PRO™-3 fluorescence mainly in lung immune cells of mice in a P2RX7-dependant manner.ConclusionsThe described approach has allowed the successful analysis of P2RX7 activity directly in the lungs of WT and transgenic C57BL6 mice. The provided detailed guidelines and recommendations will support the use of this protocol to study the potency of pharmacologic or biologic compounds targeting P2RX7.
[发布日期] 2022-12-13 [发布机构] 
[效力级别]  [学科分类] 
[关键词] P2RX7;P2X7 receptor;Purinergic receptors;ATP;Macropore;TOPRO-3;Activity [时效性] 
   浏览次数:3      统一登录查看全文      激活码登录查看全文